Essential Healthcare 2020 Limited - Accounts to registrar (filleted)

REGISTERED NUMBER: 12751952 (England and Wales)

Unaudited Financial Statements for the Year Ended 31 March 2025

for

Essential Healthcare 2020 Limited

Trading as

Abbeyrose Court Nursing Home

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr H K Chawdary

Mrs N Chawdary

REGISTERED OFFICE:

1 Coton Lane

Birmingham

B23 6TP

REGISTERED NUMBER:

12751952 (England and Wales)

FIXED ASSETS

Intangible assets

4

1

Tangible assets

5

578,160

584,764

578,161

584,765

CURRENT ASSETS

Stocks

4,020

6,700

Debtors

6

632,947

253,729

Cash at bank and in hand

182,686

629,576

819,653

890,005

CREDITORS

Amounts falling due within one year

7

1,242,470

344,538

NET CURRENT (LIABILITIES)/ASSETS

(422,817

)

545,467

TOTAL ASSETS LESS CURRENT
LIABILITIES

155,344

1,130,232

CREDITORS

Amounts falling due after more than one
year

8

(115,764

)

(594,358

)

PROVISIONS FOR LIABILITIES

(5,754

)

(5,403

)

NET ASSETS

33,826

530,471

CAPITAL AND RESERVES

Called up share capital

240

Retained earnings

33,586

530,231

SHAREHOLDERS' FUNDS

33,826

530,471

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 December 2025 and were signed on its behalf by:

Mr H K Chawdary - Director

Mrs N Chawdary - Director

1.	STATUTORY INFORMATION

Essential Healthcare 2020 Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2020, is being amortised evenly over its estimated useful life of ten years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Website is being amortised evenly over its estimated useful life of three years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Land and buildings

-

2% on cost and Straight line over 50 years

Plant and machinery etc

-

20% on reducing balance and 15% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 57 (2024 - 57 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

Goodwill

assets

Totals

£

COST

At 1 April 2024

and 31 March 2025

1

1,108

1,109

AMORTISATION

At 1 April 2024

and 31 March 2025

-

1,108

NET BOOK VALUE

At 31 March 2025

1

-

1

At 31 March 2024

1

-

1

5.	TANGIBLE FIXED ASSETS

Plant and

Land and

machinery

buildings

etc

Totals

£

COST

At 1 April 2024

570,359

55,677

626,036

Additions

-

7,485

At 31 March 2025

570,359

63,162

633,521

DEPRECIATION

At 1 April 2024

25,983

15,289

41,272

Charge for year

7,605

6,484

14,089

At 31 March 2025

33,588

21,773

55,361

NET BOOK VALUE

At 31 March 2025

536,771

41,389

578,160

At 31 March 2024

544,376

40,388

584,764

6.

DEBTORS

31.3.25

31.3.24

£

Amounts falling due within one year:

Trade debtors

76,870

169,851

Other debtors

14,424

83,878

91,294

253,729

Amounts falling due after more than one year:

Amounts owed by associates

541,653

-

Aggregate amounts

632,947

253,729

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

Trade creditors

76,012

82,642

Taxation and social security

1,044,245

187,525

Other creditors

122,213

74,371

1,242,470

344,538

8.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

31.3.25

31.3.24

£

Amounts owed to associates

-

53,831

Other creditors

115,764

540,527

115,764

594,358

9.	ULTIMATE CONTROLLING PARTY

The Board of Directors are the controlling party.

10.	COMPANY RESTRUCTURING

Business Re-organisation - 28 October 2024

Transactions phase 1:

a) Reactive Finance Limited purchase 56C ordinary shares of £1 in Essential Healthcare 2020 Limited from Rotara Limited for cash consideration of £469,000

b) Reactive Finance Limited purchase 12D & 12E ordinary shares of £1 each in Essential Healthcare 2020 Limited from Mr Satvinder Sekhon for cash consideration of £200,500

Transactions phase 2:

a) Reactive Finance Limited purchase 56B ordinary shares of £1 each in Essential Healthcare 2020 Limited from Apex 2020 Limited for cash consideration of £469,000

b) Reactive Finance Limited purchase 12D & 12E ordinary shares of £1 each in Essential Healthcare 2020 Limited from Mr Manjinder Bahia for cash consideration of £200,500

All relevant legal documents were executed by Shoosmiths Solicitors.

Shares valuation were executed by RA Valuation Services Limited.

Professional advice and report were provided by KPMG LLP.